Topic: Drug-delivery

Shares of CureVac (NSDQ:CVAC) continue to rise after the company reportedly raised $213.3 million in […]

Medtronic’s plan to acquire first-to-market connected insulin pen maker Companion Medical is the medtech giant’s […]

Medtronic made medtech headlines last week when it announced it would acquire Companion Medical, the […]

Medtronic (NYSE:MDT) today said it would acquire insulin pen manufacturer Companion Medical for an undisclosed amount. […]

Fractyl Laboratories has raised $55 million in a series E round as venture capital in […]

Inovio Pharmaceuticals (NSDQ:INO) announced that it received $71 million from the U.S. Defense Dept. to support […]

Inovio Pharmaceuticals (NSDQ:INO) announced that it received $71 million from the U.S. Defense Dept. to support […]

Inovio Pharmaceuticals (NSDQ:INO) announced that it received $71 million from the U.S. Defense Dept. to support […]

Smiths Medical announced today that it has landed a federal contract to produce more than […]

Teva (NYSE:TEVA) announced today that it has launched a Bluetooth-enabled version of its ProAir albuterol sulfate […]

Dive Brief: Abbott has laid out plans to begin a U.S. study this month of […]

Continuous IV monitoring system developer ivWatch announced that it received FDA clearance for its new SmartTouch disposable […]

Continuous IV monitoring system developer ivWatch filed an SEC Form D to confirm the sale of $1.5 […]

Thermo Fisher Scientific (NYSE:TMO) announced today that it estimates revenue growth for its recently ended second […]

Tandem Diabetes Care (NSDQ:TNDM) said today that it has purchased Sugarmate — as mobile app that helps people […]

Insulet delivered the first outpatient data and at-home evaluations of its upcoming Omnipod 5—the tubeless, […]

AI-powered digital therapeutics startup Kaia Health today announced it has raised a $26 million round. […]

Dive Brief: The U.K.’s Medicines and Healthcare products Regulatory Agency on Monday posted a field […]

Dive Brief: Abbott has received FDA clearance for the latest version of its blockbuster FreeStyle […]

The 80th Scientific Sessions of the American Diabetes Association (ADA) — which are virtual this […]

Bigfoot Biomedical has brought on Dr. Jim Malone — a 21-year clinical research veteran at […]

Dive Brief: The American Diabetes Association’s 80th Scientific Sessions begins Friday with two much-anticipated data […]

Medtronic (NYSE:MDT) announced today that it received CE Mark approval in Europe for its MiniMed 790G […]

Surmodics (NSDQ:SRDX) announced today that it received CE Mark approval in Europe for its SurVeil drug-coated […]

Respira Technologies (West Hollywood, Calif.) announced the launch of a pharmaceutical-focused commercial development program for its […]

Insulet (NSDQ:PODD) today said it has resumed its pivotal study of its next-generation Omnipod Insulin Management […]

This morning Bigfoot Biomedical, a diabetes startup focused on automating insulin delivery through a connected insulin pen, […]

A medtech company developing a biodegradable intraocular lens that can release drugs directly into the […]

Merck has exercised its option to use Vaxxas‘ High Density Microarray Patch (HD-MAP) platform as a […]

Like the rest of the medical device industry, diabetes tech is adapting to the challenges […]

Severely ill COVID-19 patients may need multiple medications delivered by infusion pumps. Manufacturers and hospitals […]

Hovione Technology’s 8Shot Dry Powder Inhaler (DPI) has earned the Red Dot 2020 Product Design […]

B. Braun Medical announced that it received FDA emergency use authorization to use  its infusion pumps […]

The FDA approved the first generic version of the Proventil HFA (albuterol sulfate) metered-dose inhaler […]

Nemaura Medical (NSDQ:NMRD) announced today that it is planning to immediately repurpose its SugarBeat continuous glucose […]

Dive Brief: A 10-year study has found percutaneous coronary intervention (PCI) with drug-eluting stents is […]

Biostage (NSDQ:BSTG) this week announced that its Cellspan Esophageal Implant investigational new drug application won FDA […]

Dive Brief: Senseonics CEO Tim Goodnow cited the pricing of Abbott’s continuous glucose monitor FreeStyle […]

BD is recalling hundreds of thousands of its Alaris infusion pumps and vital sign monitors […]